David Bearman Overview
Dr. David Bearman—also known as David Bearman, david bearman md, and dr david bearman—occupies the intersection of medicine and international business. He is a respected medical cannabis clinician as well as a strategic Aventum Group leader. His professional life combines healthcare experience with corporate acumen. This dual background in healthcare knowledge and corporate know-how makes him a remarkable individual. An understanding of his career and david bearman net worth demonstrates profound impact in both industries.
David Bearman Education and Experience in Medicine
Dr. David Bearman MD spent more than 40 years working on drug abuse prevention and treatment. He has also directed programs in public health and primary care. His initial experience involved serving as co-director of the Haight-Ashbury Drug Treatment Program. He was also a consultant to Governor Reagan’s Task Force. He consulted with many medical and educational groups.
His leadership consists of service with the American Academy of Cannabinoid Medicine. The Santa Barbara Medical Society handed him their Humanitarian Award. Basically, they recognized the guy for actually caring about his patients, not just ticking boxes, and for giving a damn about the community’s health too.
Leader in Medical Cannabis
Dr. Bearman has been an integral part of the medical application of cannabis. He authored Drugs Are NOT the Devil’s Tools and Cannabis Medicine: A Guide to the Practice of Cannabinoid Medicine. These books helped inform physicians and alleviate stigma. His presentations at conventions such as MediCannaCon demonstrate his position as a credible speaker. His message is further reinforced by his fifty years of experience in public health.
He assists in bridging the divide between patient care, policy, and science. Cannabis has gained more acceptance in medical settings as a result of his efforts.
Position of Leadership at Aventum
Another Dr. Bearman is the founder and CEO of Aventum Group. He began the firm in 1996 at the age of 18. Over time, he expanded it from a modest broker to a global insurance powerhouse. Today, Aventum manages more than $1.1 billion in gross premiums. It owns significant underwriting companies such as Rokstone and Consilium.
Bearman’s approach involved investments in compliance, talent, and brand. Through this, Aventum is debt-free. His guidance amidst global changes such as a pandemic united and tightened the business. This involved creating Aventum from several brands in 2021.
Important Contributions and Accomplishments
Dr. Bearman has left a mark both in medicine and business.
- In Cannabis Medicine: He directed clinical research and informed the public. His leadership made cannabis respectable in medical circles.
- At Aventum: He expanded the business to a global leader. He developed specialty products and built the company on six continents.
Both trajectories highlight an importance on quality, longer-term planning, and innovation. His decisions have impacted the cannabis space as well as the insurance space.
Financial Success and David Bearman Net Worth
The name “David Bearman” is applied to two individuals. This makes it difficult to estimate net worth accurately.
- The Aventum CEO is estimated to have a net worth of tens of millions. Aventum generates more than $31 million in yearly EBITDA. The company has good cash flow and good market position.
- Another David—presumably a third individual—has a net worth of $5.8 million reported based on Atherogenics and Hughes Supply holdings.
These two are frequently confused in “david bearman net worth” searches. So it’s necessary to pair the appropriate name with the proper career.
Media, Education, and Public Speaking
Dr. Bearman delivers and teaches at cannabis medicine conferences. His presentations assist physicians with cannabinoid treatment. He has authored scholarly articles. These have influenced cannabis policy and public health policy.
Aventum’s CEO provides insights at international events in business. His management style is transparent, one that fosters culture and long‑term development. Aventum was a Best Place to Work in 2025, as listed by The Sunday Times.
Honours and Awards
Dr. Bearman has received numerous awards. The Santa Barbara Medical Society recognized him for humanitarian activities. He also heads professional associations in cannabinoid medicine.
The company David has achieved international acclaim as well. Aventum won awards from industry associations. His name also features in top 100 insurance leader rankings. Such recognition is evidence of vision and strong leadership.
Values and Personal Life
Dr. Bearman
values access to healthcare and community service. His free clinic work reflects a lifelong calling.
The Aventum CEO
supports career and family. His son, Oliver Bearman, made his Formula 1 debut in 2024. He espouses a “one family” business culture—founded on growth and respect.
Their values influence their work. Both men uphold excellence, integrity, and innovation.
Final Thoughts
There are two great professionals by the name David Bearman. One is a leader in cannabinoid medicine. The other is a leader of an international insurance group. Although they are not the same individual, each has created strong legacies.
- Dr. David Bearman is a medical expert and advocate.
- David Bearman of Aventum is a successful business founder and CEO.
Searches like “David Bearman MD, david bearman md, dr david bearman, david bearman net worth, david bearman aventum” reveal overlapping identities. However, knowing their separate achievements shows the full picture.
Each one has made a lasting mark in his field. Whether helping patients or building companies, they show what strong leadership can achieve.
